文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

微循环障碍与创伤性失血性休克后多器官功能障碍相关:MICROSHOCK研究

Microcirculatory Impairment Is Associated With Multiple Organ Dysfunction Following Traumatic Hemorrhagic Shock: The MICROSHOCK Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论创伤性失血性休克复苏后立即出现的微循环低灌注与7天多器官功能障碍综合征增加相关,微循环指标对MODS的预测优于传统指标。

多中心前瞻性纵向观察研究,纳入英国3个主要创伤中心的58例创伤性失血性休克插管通气患者,在ICU入住12小时内(D0)及24、48小时后进行舌下入射暗场显微镜检查,用食管多普勒评估心输出量。MODS定义为伤后第7天序贯器官衰竭评估评分≥6。与未发生MODS的患者相比,发生MODS者D0灌注血管密度和微循环血流指数更低,而心脏指数相似。灌注血管密度预测后续MODS的判别能力最佳(AUC 0.87),优于最高乳酸、心脏指数和最低收缩压。作者认为微循环灌注是创伤性失血性休克复苏的潜在终点。

要点

  • 创伤性失血性休克患者入住ICU 12小时内舌下灌注血管密度越低,第7天MODS风险越高(MODS组8.6±1.8 vs 无MODS组11.2±1.8 mm/mm,p<0.01)。
  • D0微循环血流指数在MODS组更低(2.6 [2.2-2.8] vs 2.8 [2.6-2.9],p<0.01),而两组心脏指数相似(2.1±0.7 vs 2.5±0.6 L/min/m²,p=0.11)。
  • 灌注血管密度预测后续MODS的AUC为0.87(0.76-0.99),优于最高乳酸AUC 0.69(0.53-0.84)、心脏指数AUC 0.66(0.49-0.83)和最低收缩压AUC 0.54(0.39-0.70)。
  • 作者认为微循环灌注是创伤性失血性休克复苏的潜在终点。

适用人群与场景

  • 英国3个主要创伤中心收治的创伤性失血性休克成人患者,插管通气,共58例。
  • 平均年龄43±19岁,损伤严重度评分29±14,初始乳酸7.3±6.1 mmol/L。

诊断标准与关键阈值

  • MODS定义:伤后第7天序贯器官衰竭评估评分≥6。

研究设计与关键结果

  • 多中心前瞻性纵向观察研究,纳入58例创伤性失血性休克插管通气患者,在ICU入住12小时内(D0)及24、48小时后行舌下入射暗场显微镜检查,用食管多普勒评估心输出量。
  • 初始复苏期间输注浓缩红细胞6 U(四分位距4-11 U)。
  • MODS组与非MODS组比较:D0灌注血管密度8.6±1.8 vs 11.2±1.8 mm/mm(p<0.01),微循环血流指数2.6 [2.2-2.8] vs 2.8 [2.6-2.9](p<0.01),心脏指数2.1±0.7 vs 2.5±0.6 L/min/m²(p=0.11)。
  • 灌注血管密度预测后续MODS的AUC 0.87(0.76-0.99),最高乳酸AUC 0.69(0.53-0.84),心脏指数AUC 0.66(0.49-0.83),最低收缩压AUC 0.54(0.39-0.70)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性纵向观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为微循环灌注是创伤性失血性休克复苏的潜在终点。
  • 作者认为微循环指标对后续MODS的预测优于传统指标(最高乳酸、心脏指数、最低收缩压)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To assess the relationship between microcirculatory perfusion and multiple organ dysfunction syndrome in patients following traumatic hemorrhagic shock.

DESIGN: Multicenter prospective longitudinal observational study.

SETTING: Three U.K. major trauma centers.

PATIENTS: Fifty-eight intubated and ventilated patients with traumatic hemorrhagic shock.

INTERVENTIONS: Sublingual incident dark field microscopy was performed within 12 hours of ICU admission (D0) and repeated 24 and 48 hours later. Cardiac output was assessed using oesophageal Doppler. Multiple organ dysfunction syndrome was defined as Serial Organ Failure Assessment score greater than or equal to 6 at day 7 post injury.

MEASUREMENTS AND MAIN RESULTS: Data from 58 patients were analyzed. Patients had a mean age of 43 ± 19 years, Injury Severity Score of 29 ± 14, and initial lactate of 7.3 ± 6.1 mmol/L and received 6 U (interquartile range, 4-11 U) of packed RBCs during initial resuscitation. Compared with patients without multiple organ dysfunction syndrome at day 7, patients with multiple organ dysfunction syndrome had lower D0 perfused vessel density (11.2 ± 1.8 and 8.6 ± 1.8 mm/mm; p < 0.01) and microcirculatory flow index (2.8 [2.6-2.9] and 2.6 [2.2-2.8]; p < 0.01) but similar cardiac index (2.5 [± 0.6] and 2.1 [± 0.7] L/min//m; p = 0.11). Perfused vessel density demonstrated the best discrimination for predicting subsequent multiple organ dysfunction syndrome (area under curve 0.87 [0.76-0.99]) compared with highest recorded lactate (area under curve 0.69 [0.53-0.84]), cardiac index (area under curve 0.66 [0.49-0.83]) and lowest recorded systolic blood pressure (area under curve 0.54 [0.39-0.70]).

CONCLUSIONS: Microcirculatory hypoperfusion immediately following traumatic hemorrhagic shock and resuscitation is associated with increased multiple organ dysfunction syndrome. Microcirculatory variables are better prognostic indicators for the development of multiple organ dysfunction syndrome than more traditional indices. Microcirculatory perfusion is a potential endpoint of resuscitation following traumatic hemorrhagic shock.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hutchings SD, Naumann DN, Hopkins P, et al. Microcirculatory Impairment Is Associated With Multiple Organ Dysfunction Following Traumatic Hemorrhagic Shock: The MICROSHOCK Study. Crit Care Med. 2018. PMID: 29957708. doi:10.1097/CCM.0000000000003275

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。